Alzheimer'S Disease Epidemiology

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder worldwide, primarily affecting older adults. Its epidemiology reveals a rising public health concern due to aging populations globally. As of recent estimates, approximately 50 million people worldwide live with dementia, with AD contributing to 60-70% of these cases. The prevalence is projected to triple by 2050, underscoring its impact on healthcare systems and economies. AD disproportionately affects women and those with a family history of the disease. Key risk factors include age, genetic predisposition (e.g., ApoE4 allele), and lifestyle factors such as cardiovascular health. Addressing AD's epidemiology necessitates enhanced awareness, early detection strategies, and ongoing research into effective treatments and preventive measures to mitigate its growing burden on societies worldwide.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp